Jaguar Health Inc. (NASDAQ: JAGX) is -50.59% lower on its value in year-to-date trading and has touched a low of $0.35 and a high of $1.60 in the current 52-week trading range. The JAGX stock was last observed hovering at around $0.42 in the last trading session, with the day’s loss setting it -0.02% off its average median price target of $5.00 for the next 12 months. It is also 92.0% off the consensus price target high of $5.00 offered by 1 analysts, but current levels are 92.0% higher than the price target low of $5.00 for the same period.
Currently trading at $0.40, the stock is -33.69% and -34.12% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.43 million and changing -5.36% at the moment leaves the stock -33.60% off its SMA200. JAGX registered -67.02% loss for a year compared to 6-month gain of -30.56%. The firm has a 50-day simple moving average (SMA 50) of $0.6341 and a 200-day simple moving average (SMA200) of $0.5485.
The stock witnessed a -41.59% loss in the last 1 month and extending the period to 3 months gives it a -18.07%, and is -20.63% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.20% over the week and 10.81% over the month.
Jaguar Health Inc. (JAGX) has around 29 employees, a market worth around $17.80M and $6.50M in sales. Distance from 52-week low is 12.84% and -75.26% from its 52-week high. The company has generated returns on investments over the last 12 months (-208.00%).
Jaguar Health Inc. (JAGX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Jaguar Health Inc. (JAGX) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Jaguar Health Inc. is expected to release its quarterly report on 11/12/2020 and quarterly earnings per share for the current quarter are estimated at -$0.14 with sales reaching $5.82M over the same period. The EPS is expected to shrink by -311.40% this year, but quarterly earnings will post 230.70% year-over-year.
Jaguar Health Inc. (JAGX) Top Institutional Holders
15 institutions hold shares in Jaguar Health Inc. (JAGX), with 4.18M shares held by insiders accounting for 10.37% while institutional investors hold 6.93% of the company’s shares. The shares outstanding are 40.27M, and float is at 37.83M with Short Float at 3.93%. Institutions hold 6.21% of the Float.
Jaguar Health Inc. (JAGX) Insider Activity
A total of 0 insider transactions have happened at Jaguar Health Inc. (JAGX) in the last six months, with sales accounting for 0 and purchases happening 0 times.